Fingerprint Dive into the research topics of 'Esorubicin in advanced endometrial cancer: an ineffective and potentially toxic therapy - A Southwest Oncology Group study'. Together they form a unique fingerprint.
- Sort by
- Weight
- Alphabetically
Esorubicin in advanced endometrial cancer: an ineffective and potentially toxic therapy - A Southwest Oncology Group study
Jacob B. Green, Stephanie Green, Robert V. O'Toole, David S. Alberts, William A. Nahhas, Darryl L. Wallace
Research output: Contribution to journal › Article › peer-review
1
Scopus
citations